C Lemaire

Tissue Distribution, Autoradiography, and Metabolism of 4‐(2′‐Methoxyphenyl)‐1‐[2′ ‐[N‐2″‐Pyridinyl)‐p‐[18F]Fluorobenzamido]ethyl]piperazine (p‐[18F]MPPF), a New Serotonin 5‐HT1A Antagonist for Positron Emission Tomography

D Comar, C. Degueldre, A. Luxen, 2000, Journal of neurochemistry.

Cerebral metabolism during vegetative state and after recovery to consciousness

S Laureys, C. Phillips, P. Maquet, 1999, Journal of neurology, neurosurgery, and psychiatry.

Differential diagnosis of Alzheimer's disease with PET.

D Comar, C. Degueldre, P. Maquet, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers.

C. Degueldre, P. Maquet, E. Salmon, 1991, Acta neurologica Belgica.

On the use of positron counting for radio-Assay in nuclear pharmaceutical production.

V O'Shea, A. Luxen, S. Pimlott, 2017, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635.

D Comar, J F Pujol, A. Luxen, 1998, Nuclear medicine and biology.

Ligands and tracers for PET studies of the 5-HT system--current status.

C Crouzel, C. Crouzel, C. Lemaire, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.

C. Lemaire, A. Plenevaux, A Plenevaux, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.